351 – 360 of 2163
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
A novel approach to population-based risk stratification, comprising individualized lifestyle intervention in Danish general practice to prevent chronic diseases : Results from a feasibility study
(
- Contribution to journal › Article
-
Mark
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy : studies in rodents and nonhuman primates
(
- Contribution to journal › Article
-
Mark
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly : awareness warranted for 2017/18 season
(
- Contribution to journal › Article
-
Mark
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2) : a population-based study of individual data for 89 828 children from 198 registries in 53 countries
(
- Contribution to journal › Article
-
Mark
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Genetic determinants of growth hormone and GH-related phenotypes
(
- Contribution to journal › Article
-
Mark
Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC
(
- Contribution to journal › Article
-
Mark
Do group dynamics affect colour morph clines during a range shift?
(
- Contribution to journal › Article
-
Mark
Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection : A Collaborative Meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
(
- Contribution to journal › Article